Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Intratumoral Dendritic Cells in Breast Cancer
NCT00499083Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- May 2006
- Primary completion
- Jul 2009
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Intus in breast cancer, sponsored by University of Nebraska. Started May 2006; status: completed.
02
Drugs
Intus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00499083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499083.